Patent holdings for IPC class A61K 31/4178

Total number of patents in this class: 3266

10-year publication summary

273
241
256
237
225
273
239
207
205
120
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4884
51
Nihon Nohyaku Co., Ltd.
326
48
POLA Pharma Inc.
77
42
Vicore Pharma AB
84
41
Daiichi Sankyo Company, Limited
1874
39
Allergan, Inc.
2345
33
Abbvie Inc.
1800
31
The Regents of the University of California
19943
30
F. Hoffmann-La Roche AG
7920
29
Achillion Pharmaceuticals, Inc.
164
29
Gilead Sciences, Inc.
2038
28
Theravida, Inc.
31
27
Merck Sharp & Dohme LLC
3742
27
Janssen Pharmaceutica N.V.
3384
24
The Johns Hopkins University
5671
23
Novartis AG
10829
22
Boehringer Ingelheim International GmbH
4644
21
Acacia Pharma Limited
40
18
Mayo Foundation for Medical Education and Research
3212
17
Eagle Pharmaceuticals, Inc.
99
17
Other owners 2669